Assessing the Incidence of Osteosarcoma Among Teriparatide Users Using Medicare Part D and State Cancer Registry Data (B3D-MC-GHBX Addendum 2.2)

First published 07/04/2017

Last updated 19/02/2024

EU PAS number:

EUPAS18117

Study

Finalised

Documents

Study protocol

Initial protocol

GHBX 2_2a

English (431.51 KB - PDF)View document

Study results

LY333334 B3D-MC-GHBX Non-interventional PASS Final Study Report Addendum 2.2_Redacted

English (717.48 KB - PDF)View document

Study report

Other information

Secondary tabs